Current advance of nanotechnology in diagnosis and treatment for malignant tumors

B Wang, S Hu, Y Teng, J Chen, H Wang, Y Xu… - … and Targeted Therapy, 2024 - nature.com
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Non-small-cell lung cancer

LEL Hendriks, J Remon, C Faivre-Finn… - Nature Reviews …, 2024 - nature.com
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is
responsible for the majority of cancer-related deaths worldwide. The management of …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 …

C Le Pechoux, N Pourel, F Barlesi, D Lerouge… - The lancet …, 2022 - thelancet.com
Background In patients with non-small-cell lung cancer (NSCLC), the use of postoperative
radiotherapy (PORT) has been controversial since 1998, because of one meta-analysis …

[HTML][HTML] Immune checkpoint inhibitors in non-small cell lung cancer: progress, challenges, and prospects

S Tang, C Qin, H Hu, T Liu, Y He, H Guo, H Yan… - Cells, 2022 - mdpi.com
Non-small cell lung cancer is one of the most common types of malignances worldwide and
the main cause of cancer-related deaths. Current treatment for NSCLC is based on surgical …

[HTML][HTML] Demystifying the results of RTOG 0617: identification of dose sensitive cardiac subregions associated with overall survival

A McWilliam, A Abravan, K Banfill, C Faivre-Finn… - Journal of Thoracic …, 2023 - Elsevier
Introduction The RTOG 0617 trial presented a worse survival for patients with lung cancer
treated in the high-dose (74 Gy) arm. In multivariable models, radiation level and whole …

Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer

KH Kim, J Oh, G Yang, J Lee, J Kim, S Gwak… - JAMA …, 2022 - jamanetwork.com
Importance Atrial fibrillation (AF) can develop following thoracic irradiation. However, the
critical cardiac substructure responsible for AF has not been properly studied. Objective To …

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer

C Rocca, T Soda, EM De Francesco, M Fiorillo… - Journal of translational …, 2023 - Springer
A large body of evidence indicates the existence of a complex pathophysiological
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …

Radiation treatment mechanisms of cardiotoxicity: a systematic review

KC Siaravas, CS Katsouras, C Sioka - International Journal of Molecular …, 2023 - mdpi.com
Radiotherapy may be used alone or in combination with chemotherapy for cancer treatment.
There are many mechanisms of radiation treatment exposure to toxicities. Our aim was to …

The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: staging and multidisciplinary management of patients with early-stage non …

EC Panel, B Kidane, M Bott, J Spicer, L Backhus… - The Journal of thoracic …, 2023 - Elsevier
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document:
Staging and multidisciplinary management of patients with early-stage non–small cell lung …